282 related articles for article (PubMed ID: 35392911)
1. Light-triggered multifunctional nanoplatform for efficient cancer photo-immunotherapy.
Yue J; Mei Q; Wang P; Miao P; Dong WF; Li L
J Nanobiotechnology; 2022 Apr; 20(1):181. PubMed ID: 35392911
[TBL] [Abstract][Full Text] [Related]
2. Near-Infrared-Triggered Photodynamic Therapy with Multitasking Upconversion Nanoparticles in Combination with Checkpoint Blockade for Immunotherapy of Colorectal Cancer.
Xu J; Xu L; Wang C; Yang R; Zhuang Q; Han X; Dong Z; Zhu W; Peng R; Liu Z
ACS Nano; 2017 May; 11(5):4463-4474. PubMed ID: 28362496
[TBL] [Abstract][Full Text] [Related]
3. Photothermal-Activatable Fe
Ge R; Liu C; Zhang X; Wang W; Li B; Liu J; Liu Y; Sun H; Zhang D; Hou Y; Zhang H; Yang B
ACS Appl Mater Interfaces; 2018 Jun; 10(24):20342-20355. PubMed ID: 29878757
[TBL] [Abstract][Full Text] [Related]
4. Targeted NIR-responsive theranostic immuno-nanomedicine combined TLR7 agonist with immune checkpoint blockade for effective cancer photothermal immunotherapy.
Yasothamani V; Vivek R
J Mater Chem B; 2022 Aug; 10(33):6392-6403. PubMed ID: 35971846
[TBL] [Abstract][Full Text] [Related]
5. Multifunctional Nanoparticles-Mediated PTT/PDT Synergistic Immune Activation and Antitumor Activity Combined with Anti-PD-L1 Immunotherapy for Breast Cancer Treatment.
Kong C; Xu B; Qiu G; Wei M; Zhang M; Bao S; Tang J; Li L; Liu J
Int J Nanomedicine; 2022; 17():5391-5411. PubMed ID: 36419717
[TBL] [Abstract][Full Text] [Related]
6. Polydopamine-based nanoplatform for photothermal ablation with long-term immune activation against melanoma and its recurrence.
Li M; Guo R; Wei J; Deng M; Li J; Tao Y; Li M; He Q
Acta Biomater; 2021 Dec; 136():546-557. PubMed ID: 34536603
[TBL] [Abstract][Full Text] [Related]
7. Peptide vaccine-conjugated mesoporous carriers synergize with immunogenic cell death and PD-L1 blockade for amplified immunotherapy of metastatic spinal.
Wang Z; Chen L; Ma Y; Li X; Hu A; Wang H; Wang W; Li X; Tian B; Dong J
J Nanobiotechnology; 2021 Aug; 19(1):243. PubMed ID: 34384429
[TBL] [Abstract][Full Text] [Related]
8. Chemo-photodynamic therapy with light-triggered disassembly of theranostic nanoplatform in combination with checkpoint blockade for immunotherapy of hepatocellular carcinoma.
Xu J; Zheng Q; Cheng X; Hu S; Zhang C; Zhou X; Sun P; Wang W; Su Z; Zou T; Song Z; Xia Y; Yi X; Gao Y
J Nanobiotechnology; 2021 Oct; 19(1):355. PubMed ID: 34717654
[TBL] [Abstract][Full Text] [Related]
9. A Homotypic Membrane-Camouflaged Biomimetic Nanoplatform with Gold Nanocrystals for Synergistic Photothermal/Starvation/Immunotherapy.
Li Z; Rong L
ACS Appl Mater Interfaces; 2021 May; 13(20):23469-23480. PubMed ID: 33999610
[TBL] [Abstract][Full Text] [Related]
10. Engineering of a dual-modal phototherapeutic nanoplatform for single NIR laser-triggered tumor therapy.
Zhang M; Qin X; Xu W; Wang Y; Song Y; Garg S; Luan Y
J Colloid Interface Sci; 2021 Jul; 594():493-501. PubMed ID: 33774405
[TBL] [Abstract][Full Text] [Related]
11. Core-Shell-Shell Multifunctional Nanoplatform for Intracellular Tumor-Related mRNAs Imaging and Near-Infrared Light Triggered Photodynamic-Photothermal Synergistic Therapy.
Cen Y; Deng WJ; Yang Y; Yu RQ; Chu X
Anal Chem; 2017 Oct; 89(19):10321-10328. PubMed ID: 28872842
[TBL] [Abstract][Full Text] [Related]
12. Cu
Xu H; Su Z; Zhang H; Zhang Y; Bao Y; Zhang H; Wu X; Yan R; Wang Z; Jin Y
Int J Pharm; 2023 Jun; 640():123002. PubMed ID: 37254284
[TBL] [Abstract][Full Text] [Related]
13. Biodegradable Materials with Disulfide-Bridged-Framework Confine Photosensitizers for Enhanced Photo-Immunotherapy.
Li D; Chen F; Cheng C; Li H; Wei X
Int J Nanomedicine; 2021; 16():8323-8334. PubMed ID: 34992368
[TBL] [Abstract][Full Text] [Related]
14. Metal-organic framework-mediated multifunctional nanoparticles for combined chemo-photothermal therapy and enhanced immunotherapy against colorectal cancer.
Liu H; Xu C; Meng M; Li S; Sheng S; Zhang S; Ni W; Tian H; Wang Q
Acta Biomater; 2022 May; 144():132-141. PubMed ID: 35307591
[TBL] [Abstract][Full Text] [Related]
15. Photothermally activatable PDA immune nanomedicine combined with PD-L1 checkpoint blockade for antimetastatic cancer photoimmunotherapy.
Lu Q; Qi S; Li P; Yang L; Yang S; Wang Y; Cheng Y; Song Y; Wang S; Tan F; Li N
J Mater Chem B; 2019 Apr; 7(15):2499-2511. PubMed ID: 32255127
[TBL] [Abstract][Full Text] [Related]
16. Photo-responsive hollow silica nanoparticles for light-triggered genetic and photodynamic synergistic therapy.
Lin X; Wu M; Li M; Cai Z; Sun H; Tan X; Li J; Zeng Y; Liu X; Liu J
Acta Biomater; 2018 Aug; 76():178-192. PubMed ID: 30078423
[TBL] [Abstract][Full Text] [Related]
17. Tumor-Targeting H
Jung E; Lee J; Lee Y; Seon S; Park M; Song C; Lee D
ACS Appl Bio Mater; 2021 May; 4(5):4450-4461. PubMed ID: 35006857
[TBL] [Abstract][Full Text] [Related]
18. Visible-Light-Triggered Prodrug Nanoparticles Combine Chemotherapy and Photodynamic Therapy to Potentiate Checkpoint Blockade Cancer Immunotherapy.
Choi J; Shim MK; Yang S; Hwang HS; Cho H; Kim J; Yun WS; Moon Y; Kim J; Yoon HY; Kim K
ACS Nano; 2021 Jul; 15(7):12086-12098. PubMed ID: 34165970
[TBL] [Abstract][Full Text] [Related]
19. Engineered nanomaterials for synergistic photo-immunotherapy.
Guo R; Wang S; Zhao L; Zong Q; Li T; Ling G; Zhang P
Biomaterials; 2022 Mar; 282():121425. PubMed ID: 35217344
[TBL] [Abstract][Full Text] [Related]
20. Combined Photodynamic and Photothermal Therapy and Immunotherapy for Cancer Treatment: A Review.
Kong C; Chen X
Int J Nanomedicine; 2022; 17():6427-6446. PubMed ID: 36540374
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
